Clinicians’ Forum on AI in Health & Medicine
The Clinicians’ Forum for health professional societies and associations will engage regularly with AI product developers in the interest of enhanced mutual comfort levels and ongoing clinician-developer collaboration and accelerated bi-directional learning.
About the Forum
The Clinicians’ Forum will gather for demonstration and consideration of developing tools, engage in meaningful dialogue, surface critical questions, and generate actionable insights to guide the responsible and effective application, evaluation and improvement of AI technologies applied by clinicians in various health and health care venues. By creating opportunities for real-time incubation of promising ideas and fostering collaboration, this effort will accelerate the safe, equitable, and transformative integration of AI into health care and enable a culture of continuous learning and improvement.
Background
AI in Health Care
Generative AI has rapidly appeared on the scene as a tool for unprecedented analysis, management and use of information in health, medicine and biomedical science. The integration of AI in health care presents important opportunities to revolutionize diagnosis, treatment development, care delivery, and outcomes. But it also presents potentially disruptive changes for the workforce, including new requirements for training and retraining; creation of new roles associated with the development, deployment, and ethical management of AI; and issues of trust in the technology and how it will be used, including the potential impact on clinicians whose activities are particularly amenable to automation. Health professionals face questions about how best to apply these technologies and their potential impact on patient care. The challenge is to ensure that the use of the technology is advanced in the most efficient, responsible, safe, and socially beneficial manner.
Steering Group
Co-Chairs


Suzanne Miyamoto is the CEO of the American Academy of Nursing (Academy). With two decades of policy, advocacy, and non-profit experience, Dr. Miyamoto provides visionary and strategic leadership to help the organization achieve its vision of healthy lives for all people.
Dr. Miyamoto is highly regarded for her expertise in public policy and developing strong partnerships to advance sound policy solutions that are evidence-based, patient-centered, and community-oriented. Throughout her career, she has worked with a wide network of stakeholders across the health care industry from insurers to consumer organizations. She is a successful leader in the development of advocacy-based coalitions reaching Congress and the Administration. Prior to her position at the Academy, Dr. Miyamoto served as the American Association of Colleges of Nursing’s (AACN) Chief Policy Officer. In her 12 years of service at AACN, Dr. Miyamoto supported the membership as a policy analyst, advocate, and strategist at the federal level. She simultaneously led the Nursing Community Coalition— the largest national nursing coalition focused on elevating the voice of the profession in health policy discussions.
Dr. Miyamoto is a member of the National Academy of Medicine’s Leadership Consortium, the National Quality Forum’s Board of Directors, the Sibley Memorial Hospital Board of Trustees, the Association of American Medical Colleges’ Research and Action Institute External Advisory Committee, and the National Minority Quality Forum’s Advisory Board. Currently, Dr. Miyamoto holds a faculty appointment at Georgetown University, School of Nursing.
Steering Group





Participating Organizations
Kickoff Meeting
Clinicians’ Forum on AI in Health & Medicine: A Mapping Conversation
To identify opportunities, special considerations, and key steps related to the establishment of a Clinicians’ Forum on AI in Health & Medicine, the NAM convened a kickoff planning meeting of key health professional organizations (e.g., medicine, nursing, pharmacy, physician associates, social work), developers, patients, and related stakeholders.
Contact Information
Questions?
For more information, please contact [email protected].